Cytoplasmic Asporin promotes cell migration by regulating TGF-β/Smad2/3 pathway and indicates a poor prognosis in colorectal cancer

被引:60
作者
Li, Hengcun [1 ]
Zhang, Zheng [1 ]
Chen, Lei [1 ]
Sun, Xiujing [1 ]
Zhao, Yu [1 ]
Guo, Qingdong [1 ]
Zhu, Shengtao [1 ]
Li, Peng [1 ]
Min, Li [1 ]
Zhang, Shutian [1 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol,Beijing Key Lab Precancerous L, Beijing Digest Dis Ctr,Natl Clin Res Ctr Digest D, Beijing 100050, Peoples R China
基金
中国国家自然科学基金;
关键词
TGF-BETA; GASTRIC-CANCER; INVASION; PROTEIN; GROWTH; SUSCEPTIBILITY; IDENTIFICATION; MECHANISMS; GENE; ASPN;
D O I
10.1038/s41419-019-1376-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Previous studies revealed that Asporin (ASPN) is a potential mediator in the development of various types of cancer as a secreted stroma protein, but the function of ASPN inside the cancer cells remains largely unknown. Here, we demonstrated a higher expression level of ASPN in colorectal cancer (CRC) than matched normal tissues, and 25% (2/8) CRC showed copy number variation (CNV) gain/amplification in ASPN gene. Both higher ASPN expression levels and ASPN CNV gain/amplification indicated a worse prognosis in CRC patients. ASPN can promote proliferation, migration, and invasion of CRC cells, and inhibit apoptosis by activating Akt/Erk and TGF-beta/Smad2/3 signalings. Further investigations revealed that ASPN interacts with Smad2/3, facilitates its translocation into nucleus, and up-regulates the expression of Epithelial-mesenchymal transition (EMT) related genes. Rescue assays confirmed that TGF-beta signaling is essential for the effects of ASPN on promoting CRC cell migration and invasion. In conclusion, ASPN promotes the migration and invasion of CRC cells via TGF-beta/Smad2/3 pathway and could serve as a potential prognostic biomarker in CRC patients.
引用
收藏
页数:14
相关论文
共 33 条
[1]   The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science [J].
Ansari, Daniel ;
Aronsson, Linus ;
Sasor, Agata ;
Welinder, Charlotte ;
Rezeli, Melinda ;
Marko-Varga, Gyorgy ;
Andersson, Roland .
JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
[2]   Colorectal cancer [J].
Brenner, Hermann ;
Kloor, Matthias ;
Pox, Christian Peter .
LANCET, 2014, 383 (9927) :1490-1502
[3]   TGF-beta in CAF-mediated tumor growth and metastasis [J].
Calon, A. ;
Tauriello, D. V. F. ;
Batlle, E. .
SEMINARS IN CANCER BIOLOGY, 2014, 25 :15-22
[4]   ASPN and GJB2 Are Implicated in the Mechanisms of Invasion of Ductal Breast Carcinomas [J].
Castellana, Barbara ;
Escuin, Daniel ;
Peiro, Gloria ;
Garcia-Valdecasas, Barbara ;
Vazquez, Tania ;
Pons, Cristina ;
Perez-Olabarria, Maitane ;
Barnadas, Agusti ;
Lerma, Enrique .
JOURNAL OF CANCER, 2012, 3 :175-183
[5]   Worldwide Variations in Colorectal Cancer [J].
Center, Melissa M. ;
Jemal, Ahmedin ;
Smith, Robert A. ;
Ward, Elizabeth .
CA-A CANCER JOURNAL FOR CLINICIANS, 2009, 59 (06) :366-378
[6]   Asporin participates in gastric cancer cell growth and migration by influencing EGF receptor signaling [J].
Ding, Qian ;
Zhang, Mei ;
Liu, Can .
ONCOLOGY REPORTS, 2015, 33 (04) :1783-1790
[7]   Mutated KRAS Results in Overexpression of DUSP4, a MAP-Kinase Phosphatase, and SMYD3, a Histone Methyltransferase, in Rectal Carcinomas [J].
Gaedcke, Jochen ;
Grade, Marian ;
Jung, Klaus ;
Camps, Jordi ;
Jo, Peter ;
Emons, Georg ;
Gehoff, Anastasia ;
Sax, Ulrich ;
Schirmer, Markus ;
Becker, Heinz ;
Beissbarth, Tim ;
Ried, Thomas ;
Ghadimi, B. Michael .
GENES CHROMOSOMES & CANCER, 2010, 49 (11) :1024-1034
[8]   Expression, regulation and function of asporin, a susceptibility gene in common bone and joint diseases [J].
Ikegawa, Shiro .
CURRENT MEDICINAL CHEMISTRY, 2008, 15 (07) :724-728
[9]  
Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
[10]   Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer [J].
Jung, Barbara ;
Staudacher, Jonas J. ;
Beauchamp, Daniel .
GASTROENTEROLOGY, 2017, 152 (01) :36-52